Your browser doesn't support javascript.
loading
Sequential glycosylations at the multibasic cleavage site of SARS-CoV-2 spike protein regulate viral activity.
Wang, Shengjun; Ran, Wei; Sun, Lingyu; Fan, Qingchi; Zhao, Yuanqi; Wang, Bowen; Yang, Jinghong; He, Yuqi; Wu, Ying; Wang, Yuanyuan; Chen, Luoyi; Chuchuay, Arpaporn; You, Yuyu; Zhu, Xinhai; Wang, Xiaojuan; Chen, Ye; Wang, Yanqun; Chen, Yao-Qing; Yuan, Yanqiu; Zhao, Jincun; Mao, Yang.
Afiliação
  • Wang S; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Ran W; School of Health and Life Sciences, University of Health and Rehabilitation Sciences, Qingdao, China.
  • Sun L; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Fan Q; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Zhao Y; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Wang B; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Yang J; Foshan Institute for Food and Drug Control, Foshan, China.
  • He Y; College of Life Science, Northwest University, Xi'an, China.
  • Wu Y; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Wang Y; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Chen L; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Chuchuay A; School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
  • You Y; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Zhu X; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Wang X; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Chen Y; Instrumental Analysis & Research Center, Sun Yat-sen University, Guangzhou, China.
  • Wang Y; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Chen YQ; Key Laboratory of Fujian-Taiwan Animal Pathogen Biology, College of Animal Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.
  • Yuan Y; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Zhao J; School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
  • Mao Y; State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China. yuanyq8@mail.sysu.edu.cn.
Nat Commun ; 15(1): 4162, 2024 May 16.
Article em En | MEDLINE | ID: mdl-38755139
ABSTRACT
The multibasic furin cleavage site at the S1/S2 boundary of the spike protein is a hallmark of SARS-CoV-2 and plays a crucial role in viral infection. However, the mechanism underlying furin activation and its regulation remain poorly understood. Here, we show that GalNAc-T3 and T7 jointly initiate clustered O-glycosylations in the furin cleavage site of the SARS-CoV-2 spike protein, which inhibit furin processing, suppress the incorporation of the spike protein into virus-like-particles and affect viral infection. Mechanistic analysis reveals that the assembly of the spike protein into virus-like particles relies on interactions between the furin-cleaved spike protein and the membrane protein of SARS-CoV-2, suggesting a possible mechanism for furin activation. Interestingly, mutations in the spike protein of the alpha and delta variants of the virus confer resistance against glycosylation by GalNAc-T3 and T7. In the omicron variant, additional mutations reverse this resistance, making the spike protein susceptible to glycosylation in vitro and sensitive to GalNAc-T3 and T7 expression in human lung cells. Our findings highlight the role of glycosylation as a defense mechanism employed by host cells against SARS-CoV-2 and shed light on the evolutionary interplay between the host and the virus.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Furina / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 / Mutação Limite: Animals / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Furina / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 / Mutação Limite: Animals / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China